Plasma renin activity after the use of a new beta-adrenergic blocking agent (I.C.I. 66,032).
D000081:Acetamides / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000328:Adult; D000804:Angiotensin II / Q000097:blood; D001794:Blood Pressure / Q000187:drug effects; D002306:Cardiac Volume / Q000187:drug effects; D003404:Creatinine / Q000097:blood; D004562:Electrocardiography; D006801:Humans; D006973:Hypertension / Q000378:metabolism; D008875:Middle Aged; D010647:Phenyl Ethers / Q000494:pharmacology; D011188:Potassium / Q000652:urine; D011412:Propanolamines / Q000494:pharmacology*; D011863:Radioimmunoassay; D012083:Renin / Q000097:blood*; D012964:Sodium / Q000652:urine
D000081:Acetamides; D000319:Adrenergic beta-Antagonists; D010647:Phenyl Ethers; D011412:Propanolamines; D000804:Angiotensin II; D012964:Sodium; D003404:Creatinine; D012083:Renin; D011188:Potassium